Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider
Nykode Therapeutics ASA (NYKD) · publisert 2023-10-27 14:15 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass | Tolket via |
|---|---|---|---|---|---|---|---|---|
| Martin Nicklasson | – | acquisition | 20 000 | 16,36 NOK | 2023-10-27 | NO0010714785 | XOSL - Oslo Stock Exchange | rules |
Vedlegg
- Attachment 231027.pdf (tekst hentet ut)
Meldingstekst
Oslo, Norway, October 27, 2023 - Primary insider Martin Nicklasson, Chair of the Board of Nykode Therapeutics ASA, has today acquired 20,000 shares in Nykode Therapeutics AS at a price of NOK 16.36 per share. Following the transaction, Martin Nicklasson holds 52,000 shares in Nykode Therapeutics ASA.
Please see further details in the attached document.